Early-life immune activation from bacterial or viral infections may increase the risk for psychiatric disorders in childhood and adolescence.

Severe mental illness is linked to a higher risk for premature death from physical illnesses like cardiovascular and respiratory diseases.

The FDA granted Priority Review to Teva's NDA for ecopipam, a selective D1 antagonist for pediatric Tourette syndrome.

Over two-thirds of patients report accessing test results through patient portals before hearing from providers.

Disparities in health care access may influence the likelihood of initiating antidepressant medications after COVID-19 exposure.

Amyloid-related imaging abnormality occurs for nearly 1 in 4 patients treated with lecanemab for MCI or mild AD with confirmed amyloid pathology.

Nearly 4 in 10 inpatient psychiatric mental health registered nurses (PMH-RNs) experience high burnout, according to a study published online July 27 in the Jou ...

A new data-driven process may help identify patients that can be served safely while seated in the emergency department.

Dr Erica Schwartz will lead the CDC following a recent confirmation vote in the Senate confirming her appointment as head of the agency.

Genome-wide association data reveals a shared genetic foundation between schizophrenia and the use of specific prescription medications.

The FDA has approved Orzeyful (oveporexton), a first-in-class oral orexin receptor 2 agonist, for the treatment of adult narcolepsy type 1.

As autism therapy utilization and spending expand rapidly, federal agencies are pushing for state oversight to manage Medicaid budget policy.